This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MiMedx Group, Inc. DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against MiMedx Group, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of November 8, 2013 -- MDXG

NEW YORK, Oct. 25, 2013 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased MiMedx Group, Inc. ("MiMedx" or the "Company") (NasdaqCM: MDXG) common stock between October 26, 2011 and September 4, 2013.

(Logo: )

For more information, click here: .

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (a) the Company violated the Public Health Service Act by unlawfully manufacturing and marketing certain unapproved biologics products; and (b) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

On September 4, 2013, MiMedx acknowledged the receipt of a letter from the Food and Drug Administration ("FDA") which stated that MiMedx's Surgical Biologics unit violated the Public Health Service Act by unlawfully manufacturing and marketing drugs at one of its plants. On this news, MiMedx securities fell more than 36%, to close at $3.85 per share on September 4, 2013.

If you suffered a loss in MiMedx you have until November 8, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit .  

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:       Levi & Korsinsky, LLP  Joseph Levi, Esq.  Eduard Korsinsky, Esq.  30 Broad Street - 24th Floor   New York, NY 10004   Tel: (212) 363-7500  Toll Free:  (877) 363-5972  Fax: (212) 363-7171

SOURCE Levi & Korsinsky, LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,819.74 +6.35 0.04%
S&P 500 2,090.97 +2.10 0.10%
NASDAQ 5,125.0650 +8.9220 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs